z-logo
Premium
Using CD34+ Cells to Stimulate Vascularization and Inhibit Encapsulation of Implantable Bioartificial Devices
Author(s) -
Sukup Michelle Rae,
Rodewald Lindsay,
Hansen Heidi,
Rodgers Victor G. J.,
Schatteman Gina C.
Publication year - 2007
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.21.5.a145-b
Subject(s) - cd34 , microbiology and biotechnology , cell encapsulation , biomedical engineering , stem cell , angiogenesis , encapsulation (networking) , scaffold , chemistry , tissue engineering , medicine , cancer research , biology , computer science , computer network
For successful engraftment of allogenic cells using a bioartificial device, the device must immunoisolate cells, be immuno‐invisible, exhibit good bulk transport characteristics, and be rapidly vascularized. Current devices are not vascularized quickly enough to maintain adequate cell viability and bulk transport, and device encapsulation is problematic. To address these issues, we tested devices consisting of a proangiogenic scaffold surrounding a cell‐encapsulating alginate core in mice. Our goal was to prevent device encapsulation while stimulating vascularization. We found that despite their proangiogenic nature, the scaffolds acted as a physical barrier, inhibiting the approach of vessels to the alginate core. We also examined the ability of CD34 + peripheral blood cells to induce vessel formation in the devices, and found that they stimulated capillary growth proximate to the device and reduced encapsulation. (CD34 + cells promote vascular growth in diabetic mice.) Because CD34 + cells from some patients are dysfunctional, clinically, it may be beneficial to use allogenic CD34 + cells. Thus, we immunesuppressed mice prior to device implantation and CD34 + cell injection. Surprisingly, immunesuppression, inhibited vessel growth and increased encapsulation. Thus, CD34 + cells may help create an optimal milieu for device implantation. Work supported by the Juvenile Diabetes Research Foundation

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here